Skye Bioscience Inc Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| 5AM VENTURE MANAGEMENT, LLC | 02/17/2026 | 9.68 M | $7.26 M | 0.00% | 24.41% |
| VERSANT VENTURE MANAGEMENT, LLC | 02/12/2026 | 2.01 M | $1.51 M | 0.00% | 5.06% |
| BAKER BROS. ADVISORS LP | 02/17/2026 | 1.45 M | $1.09 M | 0.00% | 3.66% |
| VANGUARD GROUP INC | 01/29/2026 | 882.79 K | $662.09 K | 0.00% | 2.23% |
| SPHERA FUNDS MANAGEMENT LTD. | 02/17/2026 | 478.93 K | $359.05 K | 0.00% | 1.21% |
| MILLENNIUM MANAGEMENT LLC | 02/17/2026 | 380.48 K | $285.24 K | -5.44% | 0.96% |
| BLACKROCK, INC. | 02/12/2026 | 281.84 K | $211.30 K | 0.71% | 0.71% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 02/13/2026 | 233.10 K | $174.75 K | 0.00% | 0.59% |
| GEODE CAPITAL MANAGEMENT, LLC | 02/09/2026 | 210.15 K | $157.60 K | 0.74% | 0.53% |
| SCHONFELD STRATEGIC ADVISORS LLC | 02/17/2026 | 93.41 K | $70.03 K | -92.13% | 0.24% |
| STATE STREET CORP | 02/13/2026 | 75.33 K | $56.47 K | 0.00% | 0.19% |
| CITADEL ADVISORS LLC | 02/17/2026 | 64.70 K | $48.51 K | 129.43% | 0.16% |
| XTX TOPCO LTD | 02/17/2026 | 53.04 K | $39.76 K | 100.00% | 0.13% |
| TWO SIGMA INVESTMENTS, LP | 02/17/2026 | 51.71 K | $38.76 K | -43.99% | 0.13% |
| TWO SIGMA ADVISERS, LP | 02/17/2026 | 40.98 K | $30.72 K | 100.00% | 0.10% |
| HRT FINANCIAL LP | 02/12/2026 | 27.35 K | $20.00 K | 100.00% | 0.07% |
| JANE STREET GROUP, LLC | 02/12/2026 | 24.62 K | $18.45 K | 93.26% | 0.06% |
| ENGINEERS GATE MANAGER LP | 02/17/2026 | 23.14 K | $17.35 K | 100.00% | 0.06% |
| GSA CAPITAL PARTNERS LLP | 02/06/2026 | 22.88 K | $17.00 K | 100.00% | 0.06% |
| BARCLAYS PLC | 02/13/2026 | 21.25 K | $15.93 K | -63.29% | 0.05% |
| NORTHERN TRUST CORP | 02/17/2026 | 20.14 K | $15.10 K | -30.55% | 0.05% |
| CITADEL ADVISORS LLC | 02/17/2026 | 18.00 K | $13.50 K | 100.00% | 0.05% |
| GROUP ONE TRADING, L.P. | 02/12/2026 | 17.70 K | $13.27 K | 634.32% | 0.04% |
| R SQUARED LTD | 01/30/2026 | 14.78 K | $11.08 K | 100.00% | 0.04% |
| UBS GROUP AG | 01/29/2026 | 13.29 K | $9.97 K | -55.70% | 0.03% |
| CAPITAL ADVISORS INC/OK | 01/15/2026 | 10.00 K | $7.50 K | 0.00% | 0.03% |
| SIMPLEX TRADING, LLC | 02/11/2026 | 6.33 K | $4.75 K | 100.00% | 0.02% |
| MORGAN STANLEY | 02/13/2026 | 4.27 K | $3.20 K | -13.79% | 0.01% |
| FEDERATED HERMES, INC. | 02/12/2026 | 1.16 K | $868 | 100.00% | 0.00% |
| FMR LLC | 02/17/2026 | 748 | $561 | -93.71% | 0.00% |
| BANK OF AMERICA CORP /DE/ | 02/17/2026 | 586 | $438 | 315.60% | 0.00% |
| BNP PARIBAS ARBITRAGE, SNC | 02/10/2026 | 510 | $382 | 0.00% | 0.00% |
| NATIONAL BANK OF CANADA /FI/ | 02/17/2026 | 400 | $295 | 100.00% | 0.00% |
| FORTITUDE FAMILY OFFICE, LLC | 01/15/2026 | 385 | $289 | 237.72% | 0.00% |
| JPMORGAN CHASE & CO | 02/11/2026 | 66 | $49 | 100.00% | 0.00% |
| ZURCHER KANTONALBANK (ZURICH CANTONALBANK) | 01/27/2026 | 52 | $39 | -99.82% | 0.00% |
| FEDERATION DES CAISSES DESJARDINS DU QUEBEC | 02/12/2026 | 51 | $38 | 0.00% | 0.00% |
| ROCKEFELLER CAPITAL MANAGEMENT L.P. | 03/17/2026 | 39 | $29 | 0.00% | 0.00% |
| TD WATERHOUSE CANADA INC. | 01/27/2026 | 25 | $18 | 0.00% | 0.00% |
| OPTIVER HOLDING B.V. | 02/17/2026 | 20 | $15 | 0.00% | 0.00% |
| NEWBRIDGE FINANCIAL SERVICES GROUP, INC. | 01/21/2026 | 18 | $13 | 0.00% | 0.00% |
| DYNAMIC WEALTH STRATEGIES, LLC | 02/04/2026 | 8 | $6 | 100.00% | 0.00% |
| CORECAP ADVISORS, LLC | 01/13/2026 | 8 | $6 | 100.00% | 0.00% |
| PLANTE MORAN FINANCIAL ADVISORS, LLC | 02/05/2026 | 3 | $2 | 0.00% | 0.00% |
| 02/19/2026 | 2 | $2 | 100.00% | 0.00% | |
| ADVISOR GROUP HOLDINGS, INC. | 02/17/2026 | 2 | $1 | -88.89% | 0.00% |
| WELLS FARGO & COMPANY/MN | 02/13/2026 | 1 | $1 | 0.00% | 0.00% |
| HARBOUR INVESTMENTS, INC. | 02/09/2026 | 1 | $1 | 0.00% | 0.00% |
| IFP ADVISORS, INC | 02/06/2026 | 1 | $1 | 0.00% | 0.00% |
| TUCKER ASSET MANAGEMENT LLC | 02/05/2026 | 1 | $1 | 100.00% | 0.00% |
Skye Bioscience Inc institutional Ownership - FAQ's
During the previous two years, 75 institutional investors and hedge funds held shares of Skye Bioscience Inc. The most heavily invested institutionals were:
Versant Venture Management, LLC: 2.01 M
UBS Group AG: 45,762
CoreCap Advisors, LLC: 8
Plante Moran Financial Advisors, LLC: 3
IFP Advisors, Inc: 2
Newbridge Financial Services Group, Inc.: 1
40.67% of Skye Bioscience Inc stock is owned by institutional investors.
Institutional investors have bought a total of 19.97 M shares in the last 24 months. This purchase volume represents approximately $14.38 M in transactions.